• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项cDNA分析揭示了一名黏多糖贮积症II型症状减轻患者的基因型-表型相关性不一致,该患者的艾杜糖-2-硫酸酯酶基因存在76个碱基的缺失。

A cDNA analysis disclosed the discordance of genotype-phenotype correlation in a patient with attenuated MPS II and a 76-base deletion in the gene for iduronate-2-sulfatase.

作者信息

Fukuhara Yasuyuki, Miura Ai, Yamazaki Narutoshi, So Tetsumin, Kosuga Motomichi, Yanagi Kumiko, Kaname Tadashi, Yamagata Takanori, Sakuraba Hitoshi, Okuyama Torayuki

机构信息

Division of Medical Genetics, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.

Department of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

出版信息

Mol Genet Metab Rep. 2020 Dec 10;25:100692. doi: 10.1016/j.ymgmr.2020.100692. eCollection 2020 Dec.

DOI:10.1016/j.ymgmr.2020.100692
PMID:33335838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7734304/
Abstract

We previously showed that the genotype-phenotype correlation in MPS II is well-conserved in Japan (Kosuga et al., 2016). Almost all of our patients with attenuated MPS II have missense variants, which is expected to result in residual activity of iduronate-2-sulfatase. In contrast, our patients with severe MPS II have so-called null-type disease-associated variants, such as nonsense variants, frame-shifts, gene insertions, gene deletions and rearrangement with pseudogene (), none of which are expected to result in residual activity. However, we recently encountered a patient with attenuated MPS II who had a presumable null-type disease-associated variant and 76-base deletion located in exon 1 that extended into intron 1. To investigate this discordance, we extracted RNA from the leukocytes of the patient and performed reverse transcription polymerase chain reaction. One of the bands of the cDNA analysis was found to include a nucleotide sequence whose transcript was expected to generate an almost full-length IDS mature peptide lacking only part of its signal peptide as well as only one amino acid at the end of the N-terminus. This suggests that an alternative splicing donor site is generated in exon 1 upstream of the deleted region. Based on these observations, we concluded that the phenotype-genotype discordance in this patient with MPS II was due to the decreased amount of IDS protein induced by the low level of the alternatively spliced mRNA, lacking part of the region coding for the signal peptide but including the region coding almost the full mature IDS protein. The first 25 amino acids at the N-terminus of IDS protein are a signal peptide. The alternative splice transcript has only 13 (1 M-13 L) of those 25 amino acids; 14G-25G are missing, suggesting that the exclusively hydrophobic 1 M-13 L of the signal peptide of IDS might have a crucial role in the signal peptide.

摘要

我们之前的研究表明,黏多糖贮积症II型(MPS II)的基因型-表型相关性在日本人群中得到了很好的保留(小菅等人,2016年)。几乎所有我们研究的症状较轻的MPS II患者都有错义变异,预计这会导致艾杜糖醛酸-2-硫酸酯酶有残余活性。相比之下,我们研究的症状严重的MPS II患者有所谓的无效型疾病相关变异,如无义变异、移码突变、基因插入、基因缺失以及与假基因的重排(),预计这些变异都不会产生残余活性。然而,我们最近遇到了一名症状较轻的MPS II患者,其有一个可能的无效型疾病相关变异,且外显子1中有一个76个碱基的缺失,该缺失延伸到了内含子1中。为了研究这种不一致性,我们从该患者的白细胞中提取了RNA,并进行了逆转录聚合酶链反应。在cDNA分析的条带中发现其中一个包含一个核苷酸序列,其转录本预计会产生一个几乎全长的IDS成熟肽,该肽仅缺少部分信号肽以及N端末尾的一个氨基酸。这表明在缺失区域上游的外显子1中产生了一个可变剪接供体位点。基于这些观察结果,我们得出结论,该MPS II患者的表型-基因型不一致是由于可变剪接mRNA水平较低导致IDS蛋白量减少所致,该mRNA缺少部分编码信号肽的区域,但包含几乎完整的成熟IDS蛋白编码区域。IDS蛋白N端的前25个氨基酸是信号肽。可变剪接转录本仅包含这25个氨基酸中的13个(1M - 13L);14G - 25G缺失,这表明IDS信号肽中仅有的疏水性1M - 13L可能在信号肽中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/490eb393f000/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/edfc1c2fc4f8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/d79a262dbcf2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/aa2cb2730574/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/2d531be22b36/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/490eb393f000/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/edfc1c2fc4f8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/d79a262dbcf2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/aa2cb2730574/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/2d531be22b36/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/7734304/490eb393f000/gr5.jpg

相似文献

1
A cDNA analysis disclosed the discordance of genotype-phenotype correlation in a patient with attenuated MPS II and a 76-base deletion in the gene for iduronate-2-sulfatase.一项cDNA分析揭示了一名黏多糖贮积症II型症状减轻患者的基因型-表型相关性不一致,该患者的艾杜糖-2-硫酸酯酶基因存在76个碱基的缺失。
Mol Genet Metab Rep. 2020 Dec 10;25:100692. doi: 10.1016/j.ymgmr.2020.100692. eCollection 2020 Dec.
2
Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.将分子分析扩展到艾杜糖-2-硫酸酯酶基因的启动子区域,揭示了编码序列正常的黏多糖贮积症 II 型患者的基因组改变。
Gene. 2013 Sep 10;526(2):150-4. doi: 10.1016/j.gene.2013.05.007. Epub 2013 May 21.
3
[Detection of a new mutation (1343-TT) in the iduronate-2-sulfatase gene from a Chinese patient with mucopolysaccharidosis type II].[从一名中国II型粘多糖贮积症患者中检测艾杜糖醛酸-2-硫酸酯酶基因的新突变(1343-TT)]
Zhonghua Er Ke Za Zhi. 2006 Feb;44(2):110-3.
4
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.对65个II型黏多糖贮积症(亨特综合征)家族的分子诊断:IDS基因中的16个新突变特征;艾杜糖醛酸-2-硫酸酯酶的遗传学、病理学及结构研究
Mol Genet Metab. 2016 Jul;118(3):190-197. doi: 10.1016/j.ymgme.2016.05.003. Epub 2016 May 7.
5
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.黏多糖贮积症 II 型动物模型在长期酶替代治疗下体液中的糖胺聚糖特征。
J Mol Med (Berl). 2022 Aug;100(8):1169-1179. doi: 10.1007/s00109-022-02221-3. Epub 2022 Jul 11.
6
A 3' splice site mutation of IDS gene in a Chinese family with mucopolysaccharidosis type II.一个中国黏多糖贮积症 II 型家系中 ID 基因的 3'剪接位点突变。
Gene. 2013 Oct 10;528(2):236-40. doi: 10.1016/j.gene.2013.06.084. Epub 2013 Jul 16.
7
Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.采用高灵敏度 LC/MS/MS 技术评估黏多糖贮积症 II 型小鼠模型中脑脊液硫酸乙酰肝素作为神经病理学生物标志物的价值。
Mol Genet Metab. 2018 Sep;125(1-2):53-58. doi: 10.1016/j.ymgme.2018.07.013. Epub 2018 Jul 23.
8
Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II.黏多糖贮积症II型患者中与疾病严重程度和基因型相关的认知及适应性行为
Mol Genet Metab. 2023 Nov;140(3):107652. doi: 10.1016/j.ymgme.2023.107652. Epub 2023 Jul 13.
9
Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II.狂犬病病毒糖蛋白或 gh625 与艾杜糖-2-硫酸酯酶融合用于治疗黏多糖贮积症 II 型。
Hum Gene Ther. 2024 Apr;35(7-8):232-242. doi: 10.1089/hum.2023.025. Epub 2023 Jul 7.
10
A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation.一种新型黏多糖贮积症 II 型鼠模型,携带有 iduronate-2-硫酸酯酶-P88L 突变。
Sci Rep. 2023 May 15;13(1):7865. doi: 10.1038/s41598-023-34541-w.

引用本文的文献

1
Production of active human iduronate-2-sulfatase (IDS) enzyme in Nicotiana benthamiana.在本氏烟中生产活性人艾杜糖-2-硫酸酯酶(IDS)酶。
Sci Rep. 2024 Oct 4;14(1):23066. doi: 10.1038/s41598-024-73778-x.
2
Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review.关于关键代谢紊乱遗传基础的当前认识:综述
Biology (Basel). 2022 Sep 2;11(9):1308. doi: 10.3390/biology11091308.
3
Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases.通过二代测序检测结构变异:揭示溶酶体贮积症中的缺失等位基因

本文引用的文献

1
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase.从艾杜糖-2-硫酸酯酶的结构看亨特综合征。
Nat Commun. 2017 Jun 8;8:15786. doi: 10.1038/ncomms15786.
2
Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene.脊椎动物艾杜糖醛酸2-硫酸酯酶(IDS)基因与蛋白质的比较研究:一个哺乳动物X连锁基因的进化
3 Biotech. 2017 May;7(1):22. doi: 10.1007/s13205-016-0595-3. Epub 2017 Apr 11.
3
Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases.无义抑制作为治疗溶酶体贮积症的一种方法。
Biomedicines. 2022 Jul 29;10(8):1836. doi: 10.3390/biomedicines10081836.
4
Separating gene clustering in the rare mucopolysaccharidosis disease. 罕见黏多糖贮积症中的基因聚类分离。
J Appl Genet. 2022 May;63(2):361-368. doi: 10.1007/s13353-022-00691-2. Epub 2022 Mar 24.
Diseases. 2016 Dec;4(4). doi: 10.3390/diseases4040032. Epub 2016 Oct 19.
4
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.对65个II型黏多糖贮积症(亨特综合征)家族的分子诊断:IDS基因中的16个新突变特征;艾杜糖醛酸-2-硫酸酯酶的遗传学、病理学及结构研究
Mol Genet Metab. 2016 Jul;118(3):190-197. doi: 10.1016/j.ymgme.2016.05.003. Epub 2016 May 7.
5
How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse.多少抗肌萎缩蛋白才足够:mdx小鼠中不同抗肌萎缩蛋白水平的生理后果
Hum Mol Genet. 2015 Aug 1;24(15):4225-37. doi: 10.1093/hmg/ddv155. Epub 2015 May 1.
6
An overview of Korean patients with mucopolysaccharidosis and collaboration through the Asia Pacific MPS Network.韩国黏多糖贮积症患者概述及通过亚太黏多糖贮积症网络开展的合作。
Intractable Rare Dis Res. 2014 Aug;3(3):79-86. doi: 10.5582/irdr.2014.01013.
7
Impact of Enzyme Replacement Therapy and Hematopoietic Stem Cell Therapy on Growth in Patients with Hunter Syndrome.酶替代疗法和造血干细胞疗法对亨特综合征患者生长发育的影响。
Mol Genet Metab Rep. 2014;1:184-196. doi: 10.1016/j.ymgmr.2014.04.001.
8
Growth charts for patients with Hunter syndrome.亨特综合征患者的生长图表。
Mol Genet Metab Rep. 2014;1:5-18. doi: 10.1016/j.ymgmr.2013.10.001.
9
Signal recognition particle: an essential protein-targeting machine.信号识别颗粒:一种重要的蛋白靶向机器。
Annu Rev Biochem. 2013;82:693-721. doi: 10.1146/annurev-biochem-072711-164732. Epub 2013 Feb 13.
10
Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: comparison in two siblings.伊杜硫酸酯酶酶替代疗法在婴儿早期开始治疗黏多糖贮积症 II 型的效果:两例同胞的比较。
Mol Genet Metab. 2013 Mar;108(3):172-7. doi: 10.1016/j.ymgme.2012.12.010. Epub 2013 Jan 9.